| |
| |
| |
A Nurse's Perspective of Pharmacology | |
| |
| |
Drug Action: Pharmaceutic, Pharmacokinetic, and Pharmacodynamic Phases | |
| |
| |
Nursing Process and Client Teaching | |
| |
| |
Medication Safety NEW! | |
| |
| |
Medication Administration | |
| |
| |
| |
Drug Calculations | |
| |
| |
Medications and Calculations | |
| |
| |
| |
Systems of Measurement with Conversion | |
| |
| |
| |
Methods for Calculation | |
| |
| |
| |
Calculations of Oral Dosages | |
| |
| |
| |
Calculations of Injectable Dosages | |
| |
| |
| |
Calculations of Intravenous Fluids | |
| |
| |
| |
Pediatric Drug Calculations | |
| |
| |
| |
Contemporary Issues in Pharmacology | |
| |
| |
The Drug Approval Process | |
| |
| |
Cultural and Pharmacogenetic Considerations | |
| |
| |
Drug Interaction and Over-the-Counter Drugs | |
| |
| |
Drugs of Abuse | |
| |
| |
Herbal Therapy with Nursing Implications | |
| |
| |
Pediatric Pharmacology | |
| |
| |
Geriatric Pharmacology | |
| |
| |
Medication Administration in Community Settings | |
| |
| |
The Role of the Nurse in Drug Research | |
| |
| |
| |
Nutrition and Electrolytes | |
| |
| |
Vitamin and Mineral Replacement | |
| |
| |
Fluid and Electrolyte Replacement | |
| |
| |
Nutritional Support | |
| |
| |
| |
Autonomic Nervous System Agents | |
| |
| |
Adrenergic Agonists and Adrenergic Blockers | |
| |
| |
Cholinergic Agonists and Anticholinergics | |
| |
| |
| |
Neurologic and Neuromuscular Agents | |
| |
| |
Central Nervous System Stimulants | |
| |
| |
Central Nervous System Depressants | |
| |
| |
Anticonvulsants | |
| |
| |
Drugs for Neurological Disorders: Parkinsonism and Alzheimer's Disease | |
| |
| |
Drugs for Neuromuscular Disorders: Myasthenia Gravis, Multiple Sclerosis, and Muscle Spasms | |
| |
| |
| |
Pain and Inflammation Management Agents | |
| |
| |
Antiinflammatory Drugs | |
| |
| |
Nonopioid and Opioid Analgesics | |
| |
| |
| |
Psychiatric Agents | |
| |
| |
Antipsychotics and Anxiolytics | |
| |
| |
Antidepressants and Mood Stabilizers | |
| |
| |
| |
Antibacterial Agents | |
| |
| |
Penicillins and Cephalosporins | |
| |
| |
Macrolides, Tetracyclines, Aminoglycosides, and Fluoroquinolones | |
| |
| |
Sulfonamides | |
| |
| |
| |
Antiinfective Agents | |
| |
| |
Antituberculars, Antifungals, Peptides, and Metronidazole | |
| |
| |
Antivirals, Antimalarials, and Anthelmintics | |
| |
| |
Drugs for Urinary Tract Disorders | |
| |
| |
| |
Immunologic Agents | |
| |
| |
HIV- and AIDS-Related Drugs | |
| |
| |
Vaccines | |
| |
| |
| |
Antineoplastic Agents | |
| |
| |
Anticancer Drugs | |
| |
| |
Targeted Therapies to Treat Cancer | |
| |
| |
Biologic Response Modifiers | |
| |
| |
| |
Respiratory Agents | |
| |
| |
Drugs for Upper Respiratory Disorders | |
| |
| |
Drugs for Lower Respiratory Disorders | |
| |
| |
| |
Cardiovascular Agents | |
| |
| |
Cardiac Glycosides, Antianginals, and Antidysrhythmics | |
| |
| |
Diuretics | |
| |
| |
Antihypertensives | |
| |
| |
Anticoagulants, Antiplatelets, and Thrombolytics | |
| |
| |
Antihyperlipidemics and Peripheral Vasodilators | |
| |
| |
| |
Gastrointestinal Agents | |
| |
| |
Drugs for Gastrointestinal Tract Disorders | |
| |
| |
Antiulcer Drugs | |
| |
| |
| |
Eye, Ear, and Skin Agents | |
| |
| |
Drugs for Eye and Ear Disorders | |
| |
| |
Drugs for Dermatologic Disorders | |
| |
| |
| |
Endocrine Agents | |
| |
| |
Endocrine Drugs: Pituitary, Thyroid, Parathyroid, and Adrenal Disorders | |
| |
| |
Antidiabetics | |
| |
| |
| |
Reproductive and Gender-Related Agents | |
| |
| |
Female Reproductive Cycle I: Pregnancy and Preterm Labor Drugs | |
| |
| |
Female Reproductive Cycle II: Labor, Delivery, and Preterm Neonatal Drugs | |
| |
| |
Postpartum and Newborn Drugs | |
| |
| |
Drugs for Women's Reproductive Health and Menopause | |
| |
| |
Drugs for Men's Health and Reproductive Disorders | |
| |
| |
Drugs for Disorders in Women's Health, Infertility, and Sexually Transmitted Infections | |
| |
| |
| |
Emergency Agents | |
| |
| |
Adult and Pediatric Emergency Drugs | |
| |
| |
Appendices | |
| |
| |
| |
Therapeutic Drug Monitoring (TDM) | |
| |
| |
| |
Potential Weapons of Bioterrorism | |